Brook MO, Hennessy C, Hester J, Hammad S, et al. Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation. Transplantation 2024 Jun 7. doi: 10.1097/TP.0000000000005065.
PMID: 38845088